Although elevated circulating GDF15 levels in patients with cancer have been frequently reported (Wang et al. 2017; Suzuki et al. 2021; Song et al. 2021), the conflicting effect of this cytokine in predicting disease progression or response to chemotherapeutic agents in cancer has not been fully elucidated. This evidence concerns the gene GDF15 and cancer.